首页> 外文期刊>The American Journal of Cardiology >Usefulness of Vascular Stenting With and Without Transvenous Pacing Leads for Vena Caval Obstruction Among Children and Adults With Repaired Congenital Heart Disease
【24h】

Usefulness of Vascular Stenting With and Without Transvenous Pacing Leads for Vena Caval Obstruction Among Children and Adults With Repaired Congenital Heart Disease

机译:血管支架置入和不置入静脉起搏导线对先天性心脏病修复儿童和成人静脉腔阻塞的有用性

获取原文
获取原文并翻译 | 示例
           

摘要

Vena caval obstruction (VCO) is a common complication after vascular manipulation for congenital heart disease. Long-term efficacy of stent therapy for relief of VCO and long-term stent patency with and without intrastent transvenous pacing leads (TPLs) is not well described. This was a retrospective review of patients treated for VCO, including those who received intrastent TPLs, between 1995 and 2012. Patient demographics, diagnoses, vascular pressure gradients, and vessel diameters were analyzed. Forty-one patients (mean age 23.5 +/- 10.3 years) with and without congenital heart disease underwent stent implantation, 26 of whom also received intrastent TPLs. Short-term stent implantation success in relieving obstructions was 93%. Poststent vascular pressure gradients and percentage vascular narrowing significantly improved (from 6.2 +/- 4.5 to 1.1 +/- 1.6 mm Hg and from 63.1 +/- 19.5% to 18.0 +/- 17.1%, respectively, p <0.05). On follow-up in 38 of 41 patients from 0.2 to 18 years (median 6.0), all survived; 6 (14%) required stent reintervention. Freedom from reintervention was 87% at 15 years. Patients with short-term procedural failure were at higher risk for stent reintervention. Among 27 patients with intrastent TPLs, freedom from reintervention was 96%. In 26 patients with follow-up catheterization, intrastent intimal proliferation was not significantly associated with TPL but was higher in the superior vena cava innominate vein junction compared with other stent locations (p <0.05). In conclusion, stent therapy for VCO can be successfully and safely performed with good long-term results. Pre-pacing lead stent placement for VCO is effective in allowing TPL placement with encouraging long-term patency. (C) 2015 Elsevier Inc. All rights reserved.
机译:先天性心脏病的血管操纵后,腔静脉阻塞(VCO)是常见的并发症。支架治疗对缓解VCO的长期疗效以及有无支架内静脉起搏导线(TPL)的长期支架通畅性没有很好的描述。这是对1995年至2012年间接受VCO治疗的患者(包括接受支架内TPL治疗的患者)的回顾性回顾。分析了患者的人口统计学,诊断,血管压力梯度和血管直径。有和没有先天性心脏病的41例患者(平均年龄23.5 +/- 10.3岁)接受了支架植入术,其中26例也接受了支架内TPL。短期内支架植入术在缓解阻塞方面的成功率为93%。支架后血管压力梯度和血管狭窄百分比显着改善(分别从6.2 +/- 4.5至1.1 +/- 1.6 mm Hg和从63.1 +/- 19.5%至18.0 +/- 17.1%,p <0.05)。在对41位0.2至18岁(中位数6.0岁)的患者中的38位进行随访时,所有患者均存活。 6(14%)位患者需要再次介入支架。在15年的时间里,免受再次干预的自由率为87%。短期手术失败的患者再次介入支架的风险较高。在27例支架内TPL患者中,无再次干预率为96%。在26例接受随访导管插入术的患者中,与其他支架位置相比,支架内膜内膜增生与TPL无关,但在上腔静脉无名静脉连接处更高(p <0.05)。总之,VCO支架治疗可以成功,安全地进行,并具有良好的长期效果。 VCO的预起搏导联支架置入可以有效地允许TPL放置,并鼓励长期通畅。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号